N-Acetylglucosaminlyltransferase-V (GnT-V) synthesizes GlcNAcβ1,6Man branched N-glycans both in vitro and in vivo. A paralog, GnT-Vb (or GnT-IX), has also been shown to synthesize both GlcNAcβ1,6Man branched N-and O-glycans. GnT-V is expressed in most human and rodent tissues while GnT-Vb expression is limited mainly to neural tissue and testes. It is of interest, therefore, to compare the catalytic properties and reaction kinetics of these sister enzymes. The results demonstrate that while GnT-V was fully active without exogenous cation and in the presence of EDTA, the activity of GnT-Vb was stimulated over 4-fold in the presence of 10 mM Mn ++ . The pH optimum for GnT-V was in the range of 6.5-7.0, while that of GnT-Vb was 8.0. common for glycosyltransferases active in brain. Both enzymes transferred GlcNAcβ1,6 to the Man residue of the GlcNAcβ1,2Man moiety of glycan substrates, and both enzymes acted effectively on a synthetic GlcNAcβ1,2Manα1,2Glc-O-octyl trisaccharide acceptor. Moreover, although both enzymes utilized an N-linked asialo-agalacto-biantennary glycan as an acceptor, GnT-Vb displayed an almost 2.5-fold higher apparent K m value compared to GnT-V. Conversely, GnT-Vb very efficiently glycosylated a synthetic glycopeptide, Ac-H 2 N-Val-Glu-Pro- (GlcNAcβ1,2-Man-O-) Thr-Ala-Val-CO-Ac, while GnT-V showed relatively poor activity toward this O-Man-linked glycopeptide acceptor, with a K m value of 20-fold higher than that of GnT-Vb. When the N-linked asialo-agalactobiantennary glycan acceptor was utilized with GnT-Vb, the expected triantennary β1,6-branched product was observed up to 8 h incubation. An additional product with two β1,6linked GlcNAc resides, however, was observed after prolonged (>8 h) incubation, consistent with an earlier report. This unusual tetraantennary product was observed with GnT-Vb only after substantial accumulation of the first triantennary product and not during the early stages of incubation.
Introduction
N-Acetylglucosaminyltransferase V (GnT-V) catalyzes transfer of GlcNAc in β(1,6)-linkage to the α(1,6)-linked mannose in biand tri-antennary N-linked glycans. Genomic sequences encoding the enzyme have been identified in animals ranging from C. elegans to man (Shoreibah et al. 1993; Saito et al. 1994; Warren et al. 2002) . The rodent and human enzymes differ by only one amino acid out of 814, demonstrating extremely strong sequence conservation. GnT-V is expressed in most human cell types, but its glycan product, often detected by the binding L-phytohemagglutinin (L-PHA), is not observed in mature breast and colorectal epithelia (Fernandes et al. 1991) . Increased expression of GnT-V products has been observed in many, but not all, oncogenically transformed cell types, and in the case of breast and colorectal carcinomas, the products are associated with invasiveness and poor prognosis (Zhao, Sato, et al. 2008; Zhao, Takahashi, et al. 2008) . GnT-V transcript expression can be regulated by the ras-ets signaling pathway, as well as others, and oncogene activation that affects these pathways leads to overexpression of the enzyme and its glycan products (Kang et al. 1996; Buckhaults et al. 1997) . The clustering and signaling of cell surface adhesion receptors, including several integrin subunits, N-and E-cadherin, as well as the endocytosis and signaling of the epidermal growth factor receptor, have been shown to be significantly affected by changes in GnT-V expression (Partridge et al. 2004; Guo et al. 2007; Zhao, Sato, et al. 2008 ). Some of these effects have been postulated to involve galectin-glycan ligand interactions on the cell surface, regulating surface residency times and intracellular signaling (Partridge et al. 2004) .
A sister enzyme of GnT-V has been described by two groups (Inamori et al. 2003; Kaneko et al. 2003; Kim et al. 2006 ), designated GnT-IX and GnT-Vb, respectively. In vitro, the enzyme can synthesize the β(1,6)-GlcNAc linkage to the α(1,6)-linked Man on N-linked glycans, identically to the GnT-V reaction. Moreover, transient expression of GnT-Vb in Lec4 CHO cells that lack functional GnT-V activity and L-PHA binding glycans resulted in expression of glycans on the surfaces of Lec4 that bound L-PHA at near wild-type CHO cell levels (Kaneko et al. 2003 ). In addition, using recombinant GnT-Vb purified from cell extracts and a lengthy incubation with an N-linked agalacto-biantennary glycan, an additional product was identified by NMR spectroscopy (Inamori et al. 2003) . In this unusual product, GlcNAc was also added to the α1,3-linked Man in a β1,6-linkage, synthesizing a tetraantennary structure with a GlcNAc residue linked β(1,6) to each of the alpha-linked Man residues, a unique glycan structure not previously reported (see Scheme I). Primarily because of the appearance of this unusual structure, the enzyme was termed GnT-IX by Inamori et al. These experiments demonstrated in vivo and in vitro that GnT-Vb could synthesize N-linked glycans with GlcNAc β1,6 branches. Subsequently, GnT-Vb (GnT-IX) was convincingly shown to synthesize in vitro the GlcNAc β1,6 branch on an O-Man-linked glycan, GlcNAcβ1,2-(GlcNAcβ1,6)Manα1-Ser- (Inamori et al. 2004 ). This product, however, was not observed when GnT-V was incubated with the same substrate under the same reaction conditions. The relative abilities of the enzyme to transfer to N-linked versus O-linked structures were not reported, however.
Glycans linked to Ser/Thr through an O-linked Man residue have been known in fungi for many years (e.g., Lehle et al. (1979) ). Their description and quantitation in mammals, however, has only occurred relatively recently (Yuen et al. 1997; Chai et al. 1999) . Quantitation of the levels of O-Man glycans relative to O-GalNAc glycans in rabbit brain yielded a ratio of about 1:4, respectively, a significant level for a type of glycan not recognized for many years to occur in mammalian tissues. Also described in rabbit brain were O-Man-linked glycans containing a β(1,6)branch, constituting a significant amount of the O-Man structures in this tissue. In muscle, however, glycans with this branch do not appear to be expressed at significant levels (Endo and Manya 2006) . The non-branched O-Man glycan in muscle, expressed predominantly on α-dystroglycan, is clearly essential for nerve-muscle adhesion since mutations in the glycosyltransferases that synthesize this glycan cause several human disorders with phenotypes of muscular dystrophy (Schachter et al. 2004; Endo 2005) . In brain, expression of glycosyltransferases with these mutations results in aberrant neuronal migration. GnT-Vb endogenously expressed in mouse brain is active toward an asialo-agalacto-biantennary N-linked glycan, and mice that lack GnT-V express active GnT-Vb (IX) (Inamori et al. 2006) , confirming the results of Kaneko et al. (2003) using Lec4 CHO cells that GnT-Vb activity is not dependent on expression of functional Va. The function of GnT-Vb in brain neural tissue is not as yet understood.
GnT-V and Vb show high degrees of amino acid sequence identity and similarity, particularly in their catalytic regions. Knowledge of the details of their acceptor specificities and kinetic properties, therefore, is an important first step to understand the function of these enzymes, particularly in neural tissue where they are both expressed during development and in the adult. To this end, we have studied the catalytic properties of recombinant GnT-Vb in vitro, including cation stimulation and pH optima, determined the K m values of the reaction of the enzyme with several N-and O-linked glycan substrates, and characterized the structures of some of the products, comparing these results with those obtained using GnT-V. 
Results
In order to gain insights into the acceptor specificities of GnT-V and Vb, a recombinant, soluble form of GnT-Vb without its N-terminal transmembrane domain but with a signal secretion sequence and an N-terminal His 6 tag for purification was constructed and stably expressed in HEK-293 cells using the pEAK vector system. EST human and mouse databases display two forms of GnT-Vb, one that is two amino acids longer and is likely due to a variation in transcriptional splicing (Kaneko et al. 2003) . A cDNA encoding the short form of the enzyme shown to be active when transiently expressed was constructed and expressed in HEK-293 cells. Western blot analysis using a mouse monoclonal antibody against the His 6 tag showed in cell lysates and cell supernatants, a protein band at about 100 kDa, close to the predicted molecular weight of 90 kDa (Figure 1 , lanes 1 and 2). Purification by nickel column chromatography of the secreted enzyme revealed a band at about 100 kDa by Western blotting with the anti-His 6 antibody ( Figure 1 , lane 3). Analysis of this enzyme preparation by SDS-PAGE revealed the presence of other protein bands (data not shown). Activity assays of the HEK-293 culture media with the GlcNAcβ1-2Manα1-2Glc-O-octyl acceptor and UDP-[ 3 H]-GlcNAc (Palcic et al. 1988) revealed abundant activity, and this partially purified preparation was used for subsequent experiments since no interfering hydrolase activities could be detected.
Using the synthetic trisaccharide acceptor, assay conditions were adjusted such that the recombinant GnT-Vb showed a linear increase in the rate of product formation as a function of incubation times up to 240 min or amounts of GnT-Vb (data not shown). GnT-Vb displayed relatively low activity with the trisaccharide acceptor in the absence of divalent cation, and Mn 2+ clearly stimulated GnT-Vb activity about 4-fold (Figure 2A) , by contrast to GnT-Va, which is fully active in EDTA and whose activity actually decreases in the presence of Mn 2+ (Shoreibah et al. 1992) . The same effect of cation was also demonstrated using the transiently expressed enzyme (Kaneko et al. 2003) . Optimum Mn 2+ concentration for GnT-Vb was found to be 10-40 mM; subsequent experiments were performed in the presence of 10 mM Mn 2+ . Mn 2+ was the most effective cation for stimulating activity ( Figure 2B ). The optimal pH for GnT-Vb activity was about 8.0 ( Figure 2C ), which differed from that of GnT-V, whose optimum was 6.5-7.0 (Shoreibah et al. 1992 ). In addition, GnT-Vb activity was inhibited by sodium chloride in the assay buffer at concentrations over 50 mM ( Figure 2D ). The presence of salt does not have the same stabilizing effect for GnT-Vb that was seen with GnT-V, whose activity increases in the presence of NaCl up to 0.2 M before rapidly decreasing (Shoreibah et al. 1992) . Secreted, recombinant GnT-V requires a threshold of 0.1 M NaCl, which is required to stabilize its solubility. Decreasing the concentration of NaCl to below 0.1 M causes this recombinant enzyme to precipitate (data not shown).
GnT-Vb displayed typical Michaelis-Menten kinetics with saturation at higher concentrations of UDP-GlcNAc donor and GlcNAcβ1-2Manα1-2Glc-O-octyl acceptor (data not shown). Analysis of the UDP-GlcNAc and GlcNAcβ1-2Manα1-2Glc-O-octyl reactions yielded apparent K m values of 0.56 mM and 1.82 mM, respectively (Supplementary Figure 1A , B, Table I ).
The K m value of GnT-Vb for the trisaccharide acceptor was about three times higher than that for GnT-V (supplementary Figure 2B , Table I ), while the K m for UDP-GlcNAc was about three times lower than that for GnT-V (Table I) . Kinetic analysis of the 2-aminopyridine-labeled asialo-agalacto-biantennary glycan reactions gave a K m value of 2.30 mM for GnT-Vb (supplementary Figure 1C , Table I ), almost 2.5 times higher than that for GnT-V, whose K m with this acceptor was 0.94 mM (supplementary Figure 2C , Table I ).
The reaction of GnT-Vb and the asialo-agalacto-biantennary glycan acceptor was examined in more detail since a previous Substrate specificities of GnT-V and GnT-Vb Fluorescence of the PA-tagged glycans was detected as described in Material and methods. Retention times are indicated for the substrate (Gn 2 -bi, peak a), the product with 1 GlcNAc (Gn 3 -tri, peak b), and the product with 2 GlcNAc residues (Gn 4 -tetra, peak c). study reported an unusual "double-β(1,6)branched" structure (Inamori et al. 2003 ) (Scheme I). A time course of reaction, followed by HPLC separation of substrate and products, revealed that after 2 h of reaction between GnT-Vb and the asialobiantennary structure, a single product eluting at about 20.5 min was observed (Figure 3 , peak b). After 8 h of reaction, a second product eluting at about 22 min could begin to be detected (Figure 3 , peak c). After 48 h, larger amounts of the second product allowed it to be isolated and further characterized. MALDI-MS analysis (data not shown) suggested that the first product, found in peak b, contained an additional GlcNAc residue compared to the starting material ( Figure 3 , peak a), while the mass of the secondary product observed after 48 h showed that it contained two additional GlcNAc residues compared to the starting substrate (data not shown). Subsequent NMR structural analysis ( Figure 4 ) revealed that the initial product (peak b) contained an additional GlcNAc linked β1,6to the α1,6-linked Man, the classic product of the GnT-V reaction. This is reflected in the NMR spectrum by a drastic displacement of the chemical shift signal of the anomeric proton of the Man4 residue from 4.927 to 4.877 ppm ( Figure 4C , Table II ) and by the appearance of a signal for the anomeric proton of GlcNAc 7 at 4.545 ppm ( Figure 4D , Table II ). The secondary product, Figure 3 , peak c, observed many hours after the initial rate of the reaction had occurred was shown to contain an GlcNAc linked β1,6to the α1,6-linked Man and an additional GlcNAc linked β1,6to the α1,3-linked Man, forming the unusual tetraantennary structure. This was reflected in the NMR spectrum by the appearance of a chemical shift signal for the anomeric proton for the Man 4 residue at 5.078 ppm ( Figure 4E , Table II ) and a signal for the anomeric proton of GlcNAc 7 at 4.567 ppm ( Figure 4F , Table II ). Because of the overlap of peaks b and c encountered during the pooling of fractions for subsequent NMR analysis, peak c also contains some of the triantennary structure found in peak b. These data confirm the structures described in Inamori et al. (2003) . Evidence was not found for a product with the unusual triantennary structure where the β1,6 branch occurs on the α1,3-linked Man, which would be predicted to elute in peak b. The synthesis of the "double β1,6-branched" structure, therefore, occurs from branching of the standard triantennary product, but only after a prolonged incubation. Presented with an asialo-agalacto-biantennary substrate, therefore, the product formed by GnT-Vb during the initial rate of reaction is identical to that synthesized by GnT-V, with the unusual "double-β1,6branched" structure (Scheme I) occurring only after many hours of incubation of GnT-Vb with the substrate.
The apparent K m values of GnT-Vb and Va were next determined for GlcNAcβ1,2-Man-O-benzyl. Man-O-benzyl was shown to be an acceptor for POMGnT-I (Zhang et al. 2002) ; therefore, secreted, recombinant POMGnT-I was used to synthesize the disaccharide acceptor. The K m values for GnT-Vb and -V for the benzyl-disaccharide acceptor were similar 0.61 and 0.88 mM, respectively (supplementary Figures 1D, 2D , Table I ). GnT-Vb had been shown to transfer to a GlcNAc-β1,2-Man-Opeptide acceptor (Inamori et al. 2004 ); therefore, it was of considerable interest to determine the relative K m values of GnT-Vb and -V toward a glycopeptide known to express GlcNAcβ1,2-Man-O-Ser/Thr-. A glycopeptide from α-dystroglycan with the sequence Ac-VEP[Man(α1-)O-T]AV-NH2, known to express this glycan (L. Wells, personal communication), was synthesized, glycosylated using POMGnT-I, and utilized for the kinetic measurements. Supplementary Figures 1E and 2E show the kinetic profiles for both enzymes, which revealed that GnT-Vb displayed an apparent K m of 0.05 mM toward the peptide compared to 1.1 mM for GnT-V (Table I) . These results represent the greatest difference between the two enzymes in K m values for all substrates tested, over a 20-fold difference, and show a clear distinction between the two enzymes for an O-Manlinked glycopeptide acceptor. Interestingly, GnT-V showed little difference in K m values between the benzyl-disaccharide and glycopeptide, while GnT-Vb showed over a 10-fold difference in K m values between these substrates, suggesting that the G Alvarez-Manilla et al. Fig. 4 . NMR analysis of GnTVb products. The labeled asialo-agalacto biantennary substrate was reacted with GnT-Vb, the reactions products were separated by HPLC (Figure 3) , and fractions collected. The HPLC fractions that contained the unreacted substrate (Gn 2 -bi, peak a), the triantennary product with one GlcNAc added (Gn 3 -tri, peak b), and the tetraantennary product with two GlcNAc residues added (Gn 4 -tetra, peak c) were pooled, dried, and analyzed at 25 • C using Varian 800 and 900 MHz Inova NMR spectrometers. Signals from the resulting spectra that correspond to chemical shifts of the anomeric protons are presented for peak a (panels A and B); peak b (panels C and D) and peak c (panels E and F). Chemical shifts of these anomeric signals are summarized in Table II . Panels A, C, and E represent regions of the spectra that show chemical shifts from 4.85-5.20 ppm (anomeric protons of Man 4 and Man 4 residues), and panels B, D, and F represent regions of the spectra from 4.52-4.59 ppm (anomeric protons of GlcNAc 5, GlcNAc 5 , GlcNAc 7, and GlcNAc 7 residues). Vertical dashed lines in panels A, C, and E indicate displacements of the chemical shifts of the anomeric protons of residues Man 4 and Man 4 that resulted from the addition of GlcNAc residues by GnTVb. peptide component of the glycopeptide may be recognized or accommodated in some way by GnT-Vb during the enzymatic reaction.
In order to obtain an index of the efficiency of GnT-V and GnT-Vb for the different acceptors tested in this study (Burchell et al. 1995) , the V max /K m ratios of each substrate were estimated for these enzymes from the Line Weaver-Burk plots shown in supplementary Figures 1 and 2 , and the relative V max /K m values were calculated relative to the substrate that showed the highest V max /K m for each ezyme (Table I) . GnT-V showed, on average, substantially larger V max /K m ratios than GnT-Vb. In the case of GnT-V, the substrate for which this enzyme was most efficient was the GlcNAcβ1-2Manα1-2Glc-O-octyl acceptor (V max /K m of 22.25). GnT-Vb was most efficient against the asialo-agalacto-biantennary glycan (V max /K m = 1.348). GnT-V showed very low efficiency against the O-Man-linked glycopeptide substrate (V max /K m = 0.004) with a relative V max /K m that is only 0.02% of the most efficient acceptor. GnT-Vb in contrast showed much larger efficiency against this glycopeptide acceptor (V max /K m = 0.88) with a relative V max /K m that is 65% of the most efficient substrate. These data indicate that in addition to the higher preference of GnT-Vb for the O-Man-linked glycopeptide substrate, the catalytic efficiency is substantially larger than that of GnT-V for this acceptor, indicating that GnT-Vb is much more likely to utilize the O-Man glycopeptide substrates than GnT-V.
Discussion
"Genomic paralogy" describes closely linked sets of paralogous genes located on more than one chromosomal segment (Kasahara 1999 ). An archetypical example of genomic paralogy is provided by the HOX gene clusters and their adjacent regions that are found on human chromosomes 2, 7, 12, and 17 (Ruddle et al. 1994) . Interestingly, the human GnT-Vb is located on chromosome 17q25.3, while human GnT-V is located at 2q21, similar to two genomic paralogous regions of the HOX gene cluster. The regulation of the transcription of GnT-V has been studied extensively and is controlled in part by oncogene signaling, notably through the ras-raf-ets pathway. The promoter region of GnT-Vb, by contrast, shows no similarity to that of GnT-V, and its expression is unresponsive to ets stimulation (data not shown).
Although the human GnT-Vb amino acid sequence is about 41% identical and 53% similar to that of human GnT-V and the aligned lengths are very similar, there are significant differences in the catalytic activities they encode. GnT-Vb requires divalent cation for full activity toward glycopeptide and synthetic substrates while GnT-V is fully active in EDTA and actually shows lower activity in the presence of 10 mM Mn ++ . Neither enzyme contains the DXD motif usually associated with cation binding; thus, these sister enzymes most likely contain an amino acid region that can compensate for this motif (Busch et al. 1998; Li et al. 2001) . The pH optima for the two enzymes also differ significantly. GnT-Vb shows a significantly higher optimum, similar to other glycosyltransferases expressed in neural tissue, for example, protein O-mannosyltransferase 1 (Manya et al. 2004 ) and ceramide galactosyltransferase (Koul and Jungalwala 1981) .
The results comparing K m values of GnT-Vb toward various acceptors are consistent with and extend the observations by Inamori et al. (2003) that GnT-Vb can synthesize N-linked β1,6-branched glycans in vitro. The K m of GnT-Vb toward the asialo-agalacto-biantennary structure was only 2.5 times that of GnT-V, suggesting that GnT-Vb could possibly function in the synthesis of N-linked structures in vivo in cells with no or low GnT-V activity. By contrast, the K m of GnT-Vb for the peptide-O-Man-GlcNAc substrate is over 20 times lower than that for the N-linked glycan substrate with a much greater V max /K m ratio which reflects a substantially greater catalytic efficiency, showing that its preferred substrate by far is the O-linked glycopeptide. Strictly based on K m values comparisons, GnT-V displays K m values that are relatively similar between the N-linked glycan and O-linked glycopeptide, suggesting the possibility that it could participate in the synthesis of mannosyl-O-linked glycans in vivo. However, the fact that the V max /K m ratio of GnT-V for the glycopeptide substrate is three orders of magnitude smaller than that of the N-linked glycans suggests that GnT-V would poorly glycosylate O-Man-linked glycopeptides in vivo. The relative contribution of each of these enzymes to the synthesis of N-and O-linked glycans in brain tissue and in specific neural cell types has not been studied, but will, of course, be dependent on factors such as their relative levels of expression and compartmentalization in the Golgi apparatus. Further answers to this question await analysis of glycan structures from mice that lack GnT-V and -Vb.
Many glycoprotein substrates are known for GnT-V and range from human erythropoietin (Sasaki et al. 1987) to various growth factor receptors (Partridge et al. 2004; Guo et al. 2007) . A substrate for GnT-Vb has recently been identified in neuroblastoma SH-SY5Y cells, the receptor protein tyrosine phosphatase-β (Abbott et al. 2008) . Overexpression of GnT-Vb results in an increase in the HNK epitope expression on RPTP-β, detected by the monoclonal antibody, CAT-315, which binds to predominantly O-Man-linked HNK structures. A detailed understanding of the glycan structures on RPTP-β and the apparent preference of β1,6-glycan branching of O-linked structures by GnT-Vb is clearly necessary. Moreover, changes in the expression of the CAT-315 epitope on RPTP-β, resulting from modulation of GnT-Vb expression levels, caused changes in the phosphatase activity of RPTP-β, measured toward both an exogenous and endogenous substrate. This regulation appeared to stem from differences in the ability of the receptor to dimerize on the cell surface in a galectin-dependent manner. In order to understand the function of GnT-Vb, it is clearly of interest to identify other glycoprotein substrates for GnT-Vb in neural tissue, determine if GnT-Vb glycosylation can also regulate their functions, and compare the relative in vivo substrate preferences of GnT-V and -Vb to determine common and unique glycoprotein substrates for each enzyme.
Material and methods

Materials
All biochemical and chemical reagents were purchased from Sigma Chemical Co (St. Louis, MO). All solvents were HPLC grade and purchased from Fisher Scientific. The other enzymes and reagents obtained from Sigma (Waltham, MA) included 2-aminopyridine, dextran, 2,5-dihydroxybenzoic acid (DHB) and β1,4 galactosyltransferase. Oligonucleotides were purchased from IDT (Coralville, IA). E. coli DH5α cells were purchased from Invitrogen (Carlsbad, CA). The High Pure Plasmid Isolation Kit was purchased from Roche (Indianapolis, IN) . The Qiaquick gel extraction kit and Ni 2+nitrilotriacetate (Ni-NTA) resin were purchased from Qiagen (Valencia, CA). All restriction enzymes and T4 DNA ligase were purchased from New England Biolabs (Ipswich, MA). Spodoptera frugiperda (Sf9) insect cells and Lec8 CHO cells were purchased from A.T.C.C (Manassas, VA). PEAK Stable Cells (modified HEK-293 cells) and pEAK vector were purchased from EdgeBioSystems (Gaithersburg, MD). pBS with Trypanosoma cruzi signal sequence (pBS-SS) was a gift from Dr. Kelley Moremen (University of Georgia, Athens, GA). DMEM, fetal bovine serum, penicillin/streptomycin, and SF9 media were purchased from Mediatech Inc. (Herndon, VA). C18 Sep-Pak cartridges were obtained from Waters (Milford, MA). The TSK-Amide-80 column (4.6 × 250 mm) was purchased from Tosoh Biosciences (Montgomeryville, PA). UDP-[ 3 H]GlcNAc was purchased from American Radiolabeled Chemicals (St. Louis, MO). The synthetic trisaccharide acceptor GlcNAcβ1-2Manα1-2Glc-O-octyl was purchased from Chemica Alta (Edmonton, Canada). 2-Aminopyridine (2-AP) labeled asialoagalacto-and asialo-biantennary acceptors were prepared and characterized previously (Kaneko et al. 2003 
Construction of a cDNA encoding recombinant soluble human GnT-Vb
The cDNA encoding the truncated forms of GnT-Vb was obtained by PCR using pCD-VB and pCD-VB (Kaneko et al. 2003) as a template. A 2.1 kb fragment encoding the truncated form of GnT-VB and GnT-VB(+) (amino acids 100-782/4, respectively) was amplified by PCR using primers XbaI-F298TVB: 5 -ccatctagaGCAGACAGGATGCCCCCTGG-3 , and hVB-R2385-NotI: 5 -ctcgcggccgcGCTCACAGACAGCCCTGGC ACAAG-3 (with XbaI and NotI restriction sites underlined, respectively). PCR conditions were: the PCR products were run on a 1% agarose gel to verify amplification, and the amplified fragments were purified by a gel purification kit (Qiagen). The PCR products were then subcloned into the shuttle vector pCRII-TOPO (Invitrogen), which was amplified, purified, and then digested with XbaI and NotI. The digested samples were run on a 1% agarose gel, and the inserts were purified as described above. The inserts were then subcloned downstream and in frame of a pBS vector containing an ATG start site, T. cruzi signal sequence, and a His tag (pBS-SS-His) using an AvrII and NotI site. pBS-SS-His-TVB and pBS-SS-His-TVB(+) were then amplified, purified, and digested with EcoRI and NotI to extract SS-His-TVB (−) and SS-His-TVB(+). The digested samples were run on a 1% agarose gel and the inserts were purified as described above. These inserts were cloned into the pEAK mammalian expression vector using the EcoRI and NotI cloning sites. At all stages, DNA sequences were verified by sequence analysis.
Cell culture and expression of sshGnT-VB in HEK-293 cells HEK-293 cells were grown at 37 • C with 5% CO 2 in DMEM supplemented with 10% FBS/2 mM L-Gln/100 units/mL penicillin/50 μg/mL streptomycin in T-75 flasks. HEK-293 cells were transfected with 12 μg of pEAK-GnT-VB (−) and TVB(+) using the calcium phosphate method (Chen and Okayama 1987) . Once the stable cell line was established according to the protocol prepared by the expression plasmid manufacturer, the cloned cells were maintained in culture media supplemented with 2 μg/mL puromycin. Protein expression with pEAK-GnT-Vb produces a soluble protein containing an N-terminal (His) 6 tag. GnT-Vb was partially purified using a 25 mL Ni-NTA fast flow column. GnT-Vb-containing media (500 mL) were centrifuged at 9500 rpm for 30 min to remove any cell debris. The media were then filtered using a 0.2 μm filter and brought up to 25 mM Hepes, pH 8.0, and 50 mM NaCl. The solvents used were buffer A containing 25 mM Hepes, pH 8.0, and 50 mM NaCl and buffer B containing 25 mM Hepes, pH 8.0, 50 mM NaCl, and 300 mM imidazole. The flow rate was maintained at 3 mL/min. After injection of the sample, the column was maintained at 0% B for 300 mL, followed by a linear gradient to 100% B for 300 mL. The column was maintained at 100% B for 150 mL. The column was then washed in 0% B for 100 mL. Fractions containing GnT-Vb were verified by activity assays (described below) and Western blot analysis.
Western blot analysis
The partly purified GnT-Vb was separated by SDS-PAGE (4-20% gel; Biorad) and transferred to a Biotrace PVDF membrane. The membrane was probed with a 1:1000 diluted mouse anti-His antibody. Proteins were visualized by incubation with a 1:10,000 dilution of goat anti-mouse conjugated to horseradish peroxidase followed by staining with a Western Lightning Chemiluminescence Reagent according to manufacturer's protocol.
Assays for GnT-V and Vb
GnT-V assays were performed as described (Chen et al. 1995; Buckhaults et al. 1997) . For GnT-Vb, 1.5 mL microcentrifuge tubes (assay tubes) containing 0.4 mM UDP-GlcNAc, 10 6 cpm UDP-[ 3 H]GlcNAc (25 cpm/pmol), 2 mM ADP, and 0.4 mM GlcNAcβ1-2Manα1-2Glc-O-octyl acceptor were dried under vacuum. The sample (0.005 mL) was mixed in equal parts to a buffer to give a final concentration of 25 mM HEPES, pH 8.0, 50 mM NaCl, 0.1% Triton X-100, and 10 mM MnCl 2 and was incubated in assay tubes for 1 h at 37 • C. Kinetic values were obtained for the UDP-GlcNAc donor and several acceptors using reciprocal velocity/substrate plots at different concentrations which are shown in the results section. Assays were carried out at 37 • C for times ranging from 1 to 4 h. Radiolabeled products from the GlcNAcβ1-2Manα1-2Glc-O-octyl, Man(α1-)O-benzyl, and GlcNAc(β1-2)Man(α1-)O-benzyl acceptors were purified on SepPak Plus C 18 cartridges as described (Shoreibah et al. 1993 ). Fluorescent products from 2-AP asialoagalactobiantennary and 2-AP asialo-agalacto-biantennary acceptors were analyzed by separation on a TSK-Amide column.
